|Articles|June 24, 2021
SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate
Author(s)BioPharm International Editors
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
Advertisement
Internal server error